Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASRT | ZTS | TAK | UTHR | NBIX |
| Company | Assertio Therapeutics Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.8613 | 150.97 | 13.15 | 236.83 | 139.37 |
| High | 0.8613 | 151.90 | 13.19 | 238.19 | 139.37 |
| Low | 0.7750 | 150.04 | 13.07 | 234.33 | 136.06 |
| Last | 0.7385 | 152.13 | 13.12 | 234.47 | 136.92 |
| Change | -0.1271 | +1.25 | -0.11 | -2.53 | -2.05 |
| % Change | -14.68% | +0.83% | -0.83% | -1.07% | -1.48% |
| Volume | 1,606,413 | 1,796,079 | 754,105 | 121,421 | 246,723 |
| 20-Day Average Volume | 737,318 | 4,046,453 | 1,713,818 | 515,019 | 767,456 |
| Previous Close | 0.8656 | 150.88 | 13.23 | 237.00 | 138.97 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8718 | 157.82 | 13.43 | 234.20 | 136.53 |
| 20-Day Raw Stochastic | 10.78% | 26.04% | 5.62% | 59.53% | 47.11% |
| 20-Day Relative Strength | 40.22% | 35.47% | 34.67% | 50.77% | 51.10% |
| Weighted Alpha | -66.69 | -19.48 | -21.58 | +3.62 | +37.17 |
| Today's Opinion | 100% Sell | 88% Sell | 100% Sell | 80% Buy | 96% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 100% Sell | 80% Buy | 96% Buy |
| Last Month's Opinion | 40% Sell | 40% Sell | 56% Sell | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.45% since 04/18/24 | -0.95% since 04/18/24 | -0.30% since 04/18/24 | -0.96% since 04/18/24 | +3.47% since 04/18/24 |
| Low | 0.7510 on 04/19/24 | 144.80 on 04/22/24 | 13.07 on 04/25/24 | 233.27 on 04/24/24 | 130.13 on 04/19/24 |
| High | 0.9400 on 04/23/24 | 151.90 on 04/25/24 | 13.41 on 04/23/24 | 241.00 on 04/24/24 | 145.00 on 04/23/24 |
| 1-Month | |||||
| %Chg | -25.00% since 03/25/24 | -9.62% since 03/25/24 | -7.28% since 03/25/24 | -3.93% since 03/25/24 | -2.22% since 03/25/24 |
| Low | 0.7510 on 04/19/24 | 144.80 on 04/22/24 | 13.07 on 04/25/24 | 221.53 on 04/01/24 | 130.13 on 04/19/24 |
| High | 1.0600 on 03/27/24 | 171.14 on 03/28/24 | 14.45 on 03/26/24 | 250.89 on 03/26/24 | 145.00 on 04/23/24 |
| 3-Month | |||||
| %Chg | -11.94% since 01/25/24 | -19.04% since 01/25/24 | -10.32% since 01/25/24 | +6.99% since 01/25/24 | -2.75% since 01/25/24 |
| Low | 0.7510 on 04/19/24 | 144.80 on 04/22/24 | 13.07 on 04/25/24 | 208.62 on 02/08/24 | 128.00 on 02/07/24 |
| High | 1.2100 on 03/12/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 250.89 on 03/26/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | -63.89% since 10/25/23 | -7.34% since 10/25/23 | -9.52% since 10/25/23 | +4.52% since 10/25/23 | +26.71% since 10/25/23 |
| Low | 0.7510 on 04/19/24 | 144.80 on 04/22/24 | 13.07 on 04/25/24 | 208.62 on 02/08/24 | 103.63 on 11/10/23 |
| High | 2.3700 on 11/06/23 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 258.31 on 12/14/23 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 82,338 | 69,006,328 | 41,870,544 | 11,152,981 | 13,828,489 |
| Shares Outstanding, K | 95,122 | 457,359 | 3,164,818 | 47,059 | 99,507 |
| Annual Sales | 152,070,000 | 8,544,000,000 | 29,803,340,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -331,940,000 | 2,344,000,000 | 2,345,930,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 32,990,000 | 2,213,000,000 | 7,556,070,000 | 614,700,000 | 515,200,000 |
| Last Quarter Net Income | -57,380,000 | 525,000,000 | 718,900,000 | 217,100,000 | 147,700,000 |
| 60-Month Beta | 0.96 | 0.85 | 0.53 | 0.52 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.11 on 03/11/24 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 4.36 on 02/21/24 | 1.44 on 02/07/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 7.00 | 28.11 | 6.86 | 11.82 | 57.89 |